Transplant-Associated Thrombotic Microangiopathy in a Patient With Polycystic Kidney Disease Immediately Post–Kidney Transplant: A Case Report
https://t.co/s4c5xXUK74 #OpenAccess@niten24 @Gordon7Craig @TuftsMedicalCtr#kidneytransplant#PKD
Stem-cell source, acute GVHD, infections, and hospital size most significant factors associated with LOS for allogenic stem-cell transplant https://t.co/qtej3P9DMR #JCOOP
https://t.co/gm0Hy9e6kC
Congratulations to @amangodaramd and the team
JCO Oncology Practice
Length of Stay and Hospital Costs for Patients Undergoing Allogeneic Stem-Cell Transplantation
Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Cont… https://t.co/1VL2jOhsGH
@WasifSaifMD @amangodaramd
#ASH19#MachineLearning Using ML algorithms and state level data base to predict acute myeloid leukemia treatment related in hospital mortality, independent of type of chemotherapy, performance status and disease characteristics.
Interesting story in the Times about the forensic implications of hematopoietic cell transplantation... although one of the experts they quoted sounds pretty dodgy. 😇
https://t.co/1yXUBfYiX0
Congrats to Aman @myelomAman_md -2nd year in a row we had the opportunity to present our work at #TCTM19 @CIMBTR ASBMT Oral presentation, Poster ASCT - LOS Transplant related TTP
2017 a banner year for FDA approvals in hematologic malignancies. In this graphic, purple=4 new drug approvals for AML; red=5 new drugs for ALL/NHL; orange=supplemental approvals for new indications #ASH17